. Conformational coupling of DHPR and RyR1 in skeletal myotubes is influenced by long-range allosterism: evidence for a negative regulatory module. Am J Physiol Cell Physiol 286: C179-C189, 2004. First published September 17, 2003; 10.1152/ajpcell.00176.2003.-Four ryanodine receptor type 1 and 2 chimeras (R4, R9, R10, and R16) and their respective wild-type ryanodine receptors (type 1 and 2; wtRyR1 and wtRyR2) were expressed in dyspedic 1B5 to identify possible negative regulatory modules of the Ca 2ϩ release channel that are under the influence of the dihydropyridine receptor (DHPR). Responses of intact 1B5 myotubes expressing each construct to caffeine in the absence or presence of either La 3ϩ and Cd 2ϩ or the organic DHPR blocker nifedipine were determined by imaging single 1B5 myotubes loaded with fluo 4. The presence of La 3ϩ and Cd 2ϩ or nifedipine in the external medium at concentrations known to block Ca 2ϩ entry through the DHPRs significantly decreased the caffeine EC50 of wtRyR1 (2.80 Ϯ 0.12 to 0.83 Ϯ 0.09 mM; P Ͻ 0.05). On the other hand, DHPR blockade did not significantly alter the caffeine EC50 values of wtRyR2, chimeras R10 and R16, whereas the caffeine EC50 values of chimeras R4 and R9 were significantly increased (1.27 Ϯ 0.05 to 2.60 Ϯ 0.16 mM, and 1.15 Ϯ 0.03 to 2.11 Ϯ 0.32 mM, respectively; P Ͻ 0.05). Despite the fact that all the chimeras form fully functional Ca 2ϩ release channels in situ, sarcoplasmic reticulum (SR) containing R4, R10, and R16 did not possess high-affinity binding of [ 3 H]ryanodine regardless of Ca 2ϩ concentration. These results suggest the presence of an interaction between RyR1 and the DHPR, which is not present in RyR2, that contributes negative control of SR Ca 2ϩ release induced by direct agonists such as caffeine. Although we were unable to define the negative module using RyR1-RyR2 chimeras, they further demonstrated that the RyR is very sensitive to long-range allosterism. ryanodine receptor type 1; dihydropyridine receptor; excitation-contraction coupling; negative module RYANODINE RECEPTORS (RyRs) and dihydropyridine receptors (DHPRs) are the two essential proteins of excitation-contraction (EC) coupling of striated muscle (2, 39, 46) . The RyRs function as Ca 2ϩ release channels in the sarcoplasmic reticulum (SR) (13, 15, 17) . On the other hand, the DHPR has a dual-functional role, acting as both a sarcolemmal L-type voltage-gated Ca 2ϩ channel and the trigger of mechanical coupling in skeletal muscle (1, 25, 39, 47) . EC coupling in cardiac muscle is induced by the entry of extracellular Ca 2ϩ through the DHPR (25), whereas in skeletal muscle, depolarization of the sarcolemma induces conformational changes of the DHPR by the gating charge movement of its voltage sensor (41), which, in turn, activates skeletal-type RyR (RyR1) in the SR (called an orthograde signaling). The subsequent efflux of Ca 2ϩ through the activated RyR1 triggers muscle contraction (18, 41) . Direct interaction between the DHPR and RyR1 occurs via the intracellular loop between the second and third repeat domain (II-III loop) of the skeletal muscle ␣ 1s -subunit of the DHPR and is essential for skeletal-type EC coupling (18, 28, 47) . It has also been suggested that other regions of the ␣ 1s -subunit interact with RyR1, but the function of this possible interaction has not yet been addressed. In addition, the physiological mechanism for inactivation and deactivation after triggering RyRs has not yet been completely defined, although a number of endogenous inhibitors (Mg 2ϩ , H ϩ , Fe 2ϩ , lactate, sphingosine, spermine, and calmodulin-dependent kinase II) and biphasic effectors (Ca 2ϩ and calmodulin) of RyRs have been found in the cell (53).
RYANODINE RECEPTORS (RyRs) and dihydropyridine receptors (DHPRs) are the two essential proteins of excitation-contraction (EC) coupling of striated muscle (2, 39, 46) . The RyRs function as Ca 2ϩ release channels in the sarcoplasmic reticulum (SR) (13, 15, 17) . On the other hand, the DHPR has a dual-functional role, acting as both a sarcolemmal L-type voltage-gated Ca 2ϩ channel and the trigger of mechanical coupling in skeletal muscle (1, 25, 39, 47) . EC coupling in cardiac muscle is induced by the entry of extracellular Ca 2ϩ through the DHPR (25), whereas in skeletal muscle, depolarization of the sarcolemma induces conformational changes of the DHPR by the gating charge movement of its voltage sensor (41) , which, in turn, activates skeletal-type RyR (RyR1) in the SR (called an orthograde signaling). The subsequent efflux of Ca 2ϩ through the activated RyR1 triggers muscle contraction (18, 41) . Direct interaction between the DHPR and RyR1 occurs via the intracellular loop between the second and third repeat domain (II-III loop) of the skeletal muscle ␣ 1s -subunit of the DHPR and is essential for skeletal-type EC coupling (18, 28, 47) . It has also been suggested that other regions of the ␣ 1s -subunit interact with RyR1, but the function of this possible interaction has not yet been addressed. In addition, the physiological mechanism for inactivation and deactivation after triggering RyRs has not yet been completely defined, although a number of endogenous inhibitors (Mg 2ϩ , H ϩ , Fe 2ϩ , lactate, sphingosine, spermine, and calmodulin-dependent kinase II) and biphasic effectors (Ca 2ϩ and calmodulin) of RyRs have been found in the cell (53) .
Expression of the cDNA encoding RyR1 in dyspedic 1B5 myotubes (RyR1 Ϫ/Ϫ ) restores skeletal type EC coupling and rescues Ca 2ϩ current through the DHPR (27). The latter is a result of the recovered retrograde signaling from the RyR to DHPR in dyspedic muscle. Neither orthograde nor retrograde signaling is restored by expression of cDNAs encoding RyR2 or RyR3 in dyspedic myotubes (8, 29, 33, 38) . In an attempt to define which regions of RyR1 are responsible for orthograde and retrograde signaling with the DHPR, we have found that both orthograde and retrograde signaling are strongly restored by the R10 region (1,635-2,636 aa). The smaller R16 region (1,837-2,154 aa, contained within the R10 region) mediates only weak orthograde signaling. In the case of the adjacent R9 region (2,659-3,720 aa), orthograde signaling is weekly restored but retrograde signaling is strongly restored (28, 36, 38) .
In this study, allosteric interactions between the DHPR and RyR1 were further examined by expressing cDNAs encoding wild-type RyR1, RyR2, and four RyR1-RyR2 chimeras [R4, R9, and R10 based on Nakai et al. (28) , and R16 based on Proenza et al. (36) ] in 1B5 myotubes by using helper-free Herpes Simplex virus 1 (HSV-1) amplicon virions (49) . This study revealed that at rest, before activation, the DHPR exerts a negative long-range allosterism on RyR1, reducing its sensitivity to direct agonists such as caffeine. This repression can be lifted pharmacologically with DHPR blockers at concentrations that place the DHPR into the preactivated state. Using RyR1-RyR2 chimeras, we were not able to discover the location of the negative module but demonstrated that the DHPR engages long-range allosteric interactions with the R9 region of RyR1 (2,659-3,720 aa), manifested as decreased caffeine sensitivity when the DHPR was placed in a preactivated state. These results provide the first example of how long-range allosterism between the DHPR and RyR1 moderates the activity of RyR1 and Ca 2ϩ release in response to direct agonists such as caffeine.
MATERIALS AND METHODS
Materials. Fetal bovine serum, media, trypsin, EDTA, glutamine, penicillin, and streptomycin to be used in cell culture were obtained from GIBCO BRL (Grand Island, NY). Caffeine and nifedipine were obtained from Sigma Chemical (St. Louis, MO). Cell culture. The methods used to create the 1B5 cell line and derive the wild-type cell line from neonatal mice are described in detail elsewhere (6, 24) . 1B5 cells were cultured on collagen-coated 10-cm tissue culture plates, and primary myoblasts were cultured on 10-cm plates coated with ECL (Upstate Biotechnology, Lake Placid, NY) at 37°C in a 5% CO 2 incubator in low-glucose DMEM (growth medium) containing 20% fetal bovine serum, 100 U/ml penicillin, 100 g/ml streptomycin, and an additional 2 mM L-glutamine (plus 20 nM basic fibroblast growth factor in case of wild-type cell line). After ϳ48 h, the 1B5 cells were replated in 1) 96-well plates with ultrathin clear bottoms (Corning, Costar, NY) coated with Matrigel (BD Biosciences, Bradford, MA) for Ca 2ϩ imaging experiments or 2) 10-cm tissue culture plates coated with Matrigel for crude SR membrane preparations. After ϳ48 h, primary myoblasts were replated in 96-well plates with ultrathin clear bottoms coated with Matrigel for Ca 2ϩ imaging experiments. When cells reached confluence of ϳ70%, the growth medium was replaced with differentiation medium (containing 5% heat-inactivated horse serum instead of 20% fetal bovine serum in growth medium) and placed into an 18% CO 2 incubator to induce differentiation. 1B5 cells (1B5 myotubes) were subjected to viral infection 5-6 days later.
Viral infection. The cDNAs encoding for wild-type RyR1, RyR2, and four RyR1-RyR2 chimeras (see Fig. 1 ) were packaged into HSV-1 amplicon virions, using the helper virus-free packaging system. The methods have been described in detail elsewhere (9, 49) . Five to six days after differentiation was begun, 1B5 myotubes were infected with 1 ml of differentiation medium containing HSV-1 virions at 4 ϫ 10 5 infectious units/ml (a multiplicity of infection of ϳ4). This mixture was removed 2 h later and replaced with differentiation medium. The 1B5 myotubes were imaged or disrupted to prepare crude SR membrane preparations 36 h after viral infection.
Ca 2ϩ imaging. The 1B5 myotubes expressing either one of the wild-type RyR isoforms or one of the chimeras or the primary myotubes cultured on the 96-well plates were loaded with 5 M fluo 4-AM (Molecular Probes, Eugene, OR) in an imaging buffer at 37°C for 30 min. The imaging buffer consisted of 125 mM NaCl, 5 mM KCl, 2 mM KH 2PO4, 2 mM CaCl2, 25 mM HEPES, 6 mM glucose, 1.2 mM MgSO4, and 0.05% BSA (fraction V) at pH 7.4. Each well of the 96-well plates was then washed three times with 100 l of the imaging buffer. The myotubes were transferred to an inverted stage microscope equipped with an Olympus Uaop/340 ϫ40 oil-immersion objective (NA 1.35) (Nikon Diaphot300; Melville, NY). The microscope was modified to incorporate a pair of separate three-dimensional (3-D) micromanipulators on either side of the vertical post holding the condenser. The myotubes were imaged by using a PTI delta-RAM (Photon Technology International, Lawrenceville, NJ) as the light source with a 12-bit digital intensified charge-coupled device camera (Stanford Photonics, Stanford, CA). Fluo 4 in the myotubes was excited at 494 nm, and fluorescence emission was measured at 516 nm. Data were displayed and analyzed using QED Imaging software (v1.3; Pittsburgh, PA). For sensitivity, caffeine was dissolved in the imaging buffer and applications were performed via a perfusion system with a 16-channel perfusion pipette (AutoMate Scientific, Berkley, CA). The 3-D micromanipulators were used to place a pair of capillaries precisely into each well as 1) an inlet that allows delivery of the desired medium or 2) an outlet that allows suction through vacuum of the exceeding media, keeping the level of media in the well constant. The perfusion inlet was positioned about 1 mm above the imaged myotubes to allow a very efficient and rapid stimulus of the imaged area. When La 3ϩ (0.1 mM) and Cd 2ϩ (0.5 mM) or nifedipine (50 M) were used to inhibit ion permeability through DHPR, they were added to the washing solution on myotubes for 2 min before caffeine challenges and were included in all caffeine and washing solutions after that time. For measurement of SR Ca 2ϩ content of single myotubes, 10 M cyclopiazonic acid (CPA) was manually applied. The SR Ca 2ϩ contents were calculated in the following way: the maximal fluorescence after 10 M CPA challenge (F max) minus the average baseline fluorescence for the 10 s immediately preceding the challenge (Frest) was then divided by Frest. Individual caffeine sensitivity curves were fitted via the Hill equation by using Origin 4.1.
Measurements of resting Ca 2ϩ levels and membrane potentials. Double-barreled Ca 2ϩ -selective microelectrodes were prepared from piggyback borosilicate glass capillaries [PB15OF-4; outer/inner diameter (OD/ID) 1.5/0.8 mm; WPI, Salem, NJ]. In short, before being pulled, the capillaries were washed with HCl and distilled water and then dried at 150°C for 3 h. They were then pulled to a short taper with a total outside tip diameter of ϳ0.6 m, using a flaming brown micropipette puller (P-87; WPI). The 1.5-mm-OD tube was sealed by exposing the tip to dimethyl dichlorosilane, and then 24 h later the tip was backfilled with the calcium ionophore ETH 129 (Fluka, St. Louis, MO). The remainder of the barrel was backfilled with a solution of pCa 7 48 h afterward. Ca 2ϩ -selective microelectrodes were calibrated in a solution of known Ca 2ϩ concentrations (pCa 3-8) at 24°C as described previously (19) , but with the addition of 1 mM Mg 2ϩ to each solution to mimic intracellular ionic conditions. They were calibrated individually, and only those that gave a Nernstian response between pCa 3 and 7 (29.5 mV per pCa unit at 24°C) were used experimentally. Individual Ca 2ϩ -selective microelectrodes were used only for a maximum of 10-12 determinations of intracellular free Ca 2ϩ concentration. The 0.8-mm-OD barrel was backfilled with 3 M KCl (tip resistance 10-15 M) just before the determination was carried out. To prevent artifacts due to changes in the sensitivity of the Ca 2ϩ -selective microelectrode, microelectrodes were calibrated before and after the intracellular Ca 2ϩ determinations. Single myotubes were impaled with the Ca 2ϩ -selective microelectrodes while being observed through an inverted microscope (Axiovert 10; Thornwood, NJ) fitted with a ϫ40 eyepiece and a ϫ40 dry objective. The potential from the 3 M KCl barrel (V m) and the potential from the Ca 2ϩ barrel (VCae) were recorded via an amplifier (FD-223; WPI). The subtraction of Vm from VCae gives a differential signal (VCa) that represents the resting myoplasmic Ca 2ϩ concentration. The potentials V m and VCa were filtered at 200 Hz (LPF-30; WPI) to improve the signal-to-noise ratio. The recorded potentials were stored in a computer for future analysis.
Crude SR membrane preparation. Crude SR membrane preparations from the 1B5 myotubes expressing the RyR isoforms and the chimeras were prepared 36 h after viral infection. The 1B5 myotubes were collected by adding a harvest buffer (137 mM NaCl, 3 mM KCl, 8 mM Na 2HPO4, 1.5 mM KH2PO4, and 0.6 mM EDTA at pH 7.2) from 10 to 15 plates (10 cm) and were centrifuged for 10 min at 250 g at 4°C. From this, samples were kept at 4°C during all following steps. The pellet was suspended with a buffer consisting of 250 mM sucrose, 10 mM HEPES, 1 mM EDTA, pH 7.4, and protease inhibitors (10 g/ml leupeptin, 0.7 g/ml pepstatin A, 5 g/ml aprotinin, and 0.1 mM PMSF) and was then homogenized using a Polytron cell disrupter (Brinkmann Instruments, Westbury, NY). The homogenates were centrifuged for 20 min at 1,500 g, and the supernatants were recentrifuged for 1 h at 100,000 g. The pellet was finally suspended in a storage buffer consisting of 250 mM sucrose and 20 mM HEPES at pH 7.4, frozen in liquid N 2, and stored at Ϫ80°C.
[ 3 H]ryanodine binding assay. Crude SR membrane preparations (0.1 g/l) were incubated with 5 nM [ 3 H]ryanodine (58 Ci/mmol; NEN) in a binding buffer (250 mM KCl, 20 mM HEPES, and 100 M CaCl 2 at pH 7.4) at 37°C for 3 h. Nonspecific binding was assessed by the presence of 1,000-fold unlabeled ryanodine and 1 mM EGTA. Separation of the bound from the free ligand was performed by rapid filtration through Whatman GF/B glass fiber filters using a Brandel cell harvester (Gaithersburg, MD). The filters were washed with three volumes of 5 ml of ice-cold buffer containing 20 mM Tris⅐HCl, 250 mM KCl, 15 mM NaCl, and 50 M CaCl 2 at pH 7.1 and placed into vials with 5 ml of scintillation cocktail (ReadySafe; Beckman Instruments, Fullerton, CA). The remaining [
3 H]ryanodine on the filters was quantified by a liquid scintillation spectrometry. Free Ca 2ϩ concentrations in each binding assay were adjusted by adding EGTA or CaCl 2 based on the calculations from the Bound and Determined program. Individual sensitivity curves were fitted with the Hill equation by using Origin 4.1.
Statistical analysis. Results are given as means Ϯ SE, with the number of experiments reported. Significance of the differences was analyzed by the paired or unpaired t-test (GraphPad InStat, v. 2.04). Differences were considered to be significant when P Ͻ 0.05.
RESULTS

Expression of RyR cDNAs in 1B5 myotubes.
The presence of allosteric interactions between DHPR and RyR1 that influence sensitivity of SR Ca 2ϩ release to known agonist was examined in dyspedic 1B5 myotubes (24) expressing any one of four RyR1-RyR2 chimeras (R4, R9, R10, and R16) or one of their respective wild-type proteins (wtRyR1 and wtRyR2; Fig. 1 ).
To check the expression of each construct and demonstrate that it was targeted in the correct position in 1B5 myotubes, we fixed the 1B5 myotubes and stained them with the appropriate primary antibodies (data not shown). Each construct produced proteins that were clustered within intensely labeled foci. Positive foci were most densely localized at the periphery of the 1B5 myotubes, which is consistent with previous results showing the formation of the Ca 2ϩ release units in the cortical region of 1B5 myotubes (37, 38) . In addition, to check the expression of appropriate molecular weight proteins, crude SR membrane preparations obtained from the 1B5 myotubes expressing each construct were subjected to denaturing PAGE. As has been shown previously (26), both Coomassie blue staining and Western blot analysis of wtRyR1, wtRyR2, R4, R9, R10, and R16 demonstrated that the appropriate molecular weight protein for all constructs was successfully expressed in the 1B5 myotubes (data not shown).
Different sensitivities of wtRyRs and four chimeras to caffeine. Caffeine sensitivities of the individual 1B5 myotubes expressing wtRyRs and four chimeras were measured by imaging fluo 4 fluorescence (Fig. 2) . 1B5 myotubes were sequentially challenged with increasing caffeine concentrations (0.1-40 mM). Each challenge lasted 30 s, with a rest interval between doses of 30 s. Figure 2A shows representative traces of the caffeine dose-response relationship from individual 1B5 myotubes. Individual dose-response curves were fitted to the Hill equation (Fig. 2B) . EC 50 values for wtRyR1 and wtRyR2 were 2.80 Ϯ 0.12 mM (n H ϭ 2.41 Ϯ 0.15) and 0.84 Ϯ 0.11 mM (n H ϭ 2.07 Ϯ 0.53), respectively, revealing that RyR2 is ϳ3.3 times more sensitive to caffeine than RyR1 when tested in the context of 1B5 myotubes. EC 50 values of the four chimeras tested were higher than that for wtRyR2 but less than that for wtRyR1, having a rank order of wtRyR2 Ͻ R9 Ͻ R4 Ͻ R10 ϭ R16 Ͻ wtRyR1 (Table 1) .
Differential influences of DHPR blockers on the sensitivities of wtRyRs and four chimeras to caffeine. La 3ϩ and Cd 2ϩ are well-known inhibitors of voltage-dependent Ca 2ϩ channels including DHPRs (4, 30, 32) . To test how a DHPR blockade influences caffeine-induced Ca 2ϩ release mediated by activation of wtRyR1, wtRyR2, and four chimeras, the same experimental procedure utilized in the experiments shown in Fig. 2 was performed in the presence of external solutions containing 0.1 mM La 3ϩ and 0.5 mM Cd 2ϩ (Fig. 3) . Figure 3A shows representative traces of the caffeine dose-response relationship from individual 1B5 myotubes expressing wtRyRs and four chimeras in the presence of La 3ϩ and Cd
2ϩ
. Figure 3B shows the number of responding 1B5 myotubes at increasing caffeine concentrations. Blockade of DHPR with La 3ϩ and Cd 2ϩ significantly shifted the caffeine dose-response relationship for 1B5 myotubes expressing certain RyR proteins examined in the present study. Specifically, DHPR blockade of myotubes expressing wtRyR1 shifted the caffeine dose-response curve 3.4-fold to the left (EC 50 from 2.80 Ϯ 0.12 to 0.83 Ϯ 0.09 mM; P Ͻ 0.05) (Fig. 3B and Table 1 ). On the other hand, 1B5 myotubes expressing R4 and R9 responded with an approximately twofold diminished sensitivity to caffeine challenge in the presence of the DHPR blockade (EC 50 from 1.27 Ϯ 0.05 to 2.60 Ϯ 0.16 mM and from 1.15 Ϯ 0.03 to 2.11 Ϯ 0.32 mM, respectively) ( Fig. 3B and Table 1 ). Caffeine sensitivities of 1B5 myotubes expressing wtRyR2, R10, or R16 were not significantly influenced by DHPR blockade with La 3ϩ and Cd 2ϩ .
In short, La 3ϩ and Cd 2ϩ increased the caffeine sensitivity of 1B5 myotubes expressing wtRyR1 but not wtRyR2, suggesting the possibility of long-range allosteric influences between the DHPR and RyR1 that normally engage a negative regulatory module within the Ca 2ϩ release channel. Replacement of the corresponding regions of RyR2 with either the R4, R9, R10, or R16 regions of RyR1 has been shown to restore skeletal-type EC coupling (38) , but interestingly, in the present study they did not reveal the locus of the negative module in wtRyR1 and failed to restore the inhibitory influence of the DHPR on caffeine-induced Ca 2ϩ release in situ. In fact, rather than showing an increased sensitivity when the DHPR was placed into a preactivated state, there was a diminution of caffeine sensitivity of 1B5 myotubes expressing R4 and R9 under these conditions.
Effects of nifedipine on caffeine sensitivities of wtRyRs and four chimeras. The influence of La 3ϩ and Cd 2ϩ on the pattern of negative modulation of caffeine-induced Ca 2ϩ release in 1B5 myotubes expressing wtRyRs and four chimeras extended our study to the organic DHPR blocker nifedipine (Fig. 4) . Nifedipine is known as a specific inhibitor of DHPR (31) with no direct effect on RyR (50) . The same experimental procedure utilized in the experiments shown in Fig. 2 was performed in the presence of external solutions containing 50 M nifedipine. Figure 4A shows representative traces of the caffeine dose-response relationship from individual 1B5 myotubes in the presence of nifedipine. Figure 4B shows the number of responding 1B5 myotubes at increasing caffeine concentra- tions. Overall changes in the caffeine sensitivities seen when DHPR function was blocked by nifedipine were similar to those seen when the 1B5 myotubes were exposed to La 3ϩ and Cd 2ϩ . The EC 50 value for RyR1 was shifted sixfold to the left (from 2.80 Ϯ 0.12 to 0.47 Ϯ 0.02 mM) ( Table 1 ). Similar to the results obtained with La 3ϩ and Cd 2ϩ , there were no changes in the RyR2, R10, and R16, whereas the caffeine sensitivities of R4 and R9 were shifted to the right (from 1.27 Ϯ 0.05 to 2.21 Ϯ 0.11 mM and from 1.15 Ϯ 0.03 to 2.28 Ϯ 0.05 mM, respectively) ( Table 1) .
Effect of La 3ϩ and Cd 2ϩ or nifedipine on caffeine sensitivities of wild-type myotubes.
To confirm increased caffeine sensitivity of 1B5 myotubes expressing wtRyR1 in the presence of La 3ϩ and Cd 2ϩ or nifedipine, cultured wild-type myotubes originating from the skeletal muscle of neonatal mice were incubated at 2 mM caffeine in either the absence or presence of La 3ϩ and Cd
2ϩ
, and the responses were normalized to the total number of wild-type myotubes (Fig. 5) . Wild-type myotubes responded with a 2.8-fold enhanced frequency to 2 mM caffeine in the presence of La 3ϩ and Cd 2ϩ (from 32.83 Ϯ 4.76 to 90.71 Ϯ 3.57%; P Ͻ 0.05) (Fig. 5B) , which is in accordance with the shift in caffeine sensitivity seen in 1B5 myotubes expressing wtRyR1 in the presence of La 3ϩ and Cd
. Interestingly, in the presence of La 3ϩ and Cd 2ϩ , but not nifedipine, cells did not return to baseline after the 30-s washout period, making it impossible to obtain comparable caffeine dose-response curves using the standard protocol. Thus we were not able to calculate caffeine EC 50 in wild-type myotubes in the presence of La 3ϩ and Cd 2ϩ . It was possible to calculate caffeine EC 50 in wild-type myotubes in the presence of 50 M nifedipine. Figure 5C shows representative traces of the caffeine dose-response relationship from individual wild-type myotubes in the absence or presence of nifedipine. Figure 5D shows 
DISCUSSION
In this study, we expressed wtRyR1, wtRyR2, and four RyR1-RyR2 chimeras (R4, R9, R10, and R16) (Fig. 1) in differentiated 1B5 myotubes. All six constructs were shown to be targeted to the correct location by immunohistochemistry, and proteins of appropriate molecular size were identified by immunoblot as has been shown previously (26-28, 36, 38) . To test whether the DHPR has an effect on the sensitivity of the wtRyR1 to direct agonist stimulation, we examined the caffeine sensitivity of each construct in the absence or presence of DHPR inhibitors (La 3ϩ and Cd 2ϩ or nifedipine, Figs. 2-4 ). The results demonstrate that DHPR inhibition significantly enhanced the sensitivity of RyR1 to the direct channel agonist caffeine, which was confirmed in wild-type myotubes originated from skeletal muscle of neonatal mice (Fig. 5) . On the other hand, the state of the DHPR had no influence on RyR2. Attempts to isolate the region of RyR1 containing the negative module by using previously constructed RyR1-RyR2 chimeras that have been shown to restore skeletal EC coupling was not successful. R10 and R16 were not affected by DHPR blockade, and R4 and R9 showed decreased caffeine sensitivities with lower SR Ca 2ϩ contents (Fig. 6 ). In addition, the use of [ 3 H]ryanodine binding assay with crude SR membrane preparations showed that, because of intermolecular allosteric interactions, R4, R10, and R16 had completely lost their ability to bind [ 3 H]ryanodine and that R9 had a significantly reduced sensitivity (increased IC 50 ) to Ca 2ϩ inhibition compared with either wtRyR isoform, similar to the previous report of Nakai et al. (26) .
Why does the DHPR blockade alter the sensitivities of RyR1 R4 and R9 to caffeine? It has been suggested that there is a preactivated state of DHPR that can be induced by both membrane depolarization (7, 20) and binding of DHPR inhibitors such as dihydropyridines (50) . Weigl et al. (50) proposed that the preactivated state of DHPR is sufficient to activate the RyR1 in human skeletal muscle cells. In addition, Kitamura et al. (16) reported that nifedipine causes a dose-dependent potentiation of K ϩ contractures in the presence of normal extracellular Ca 2ϩ without any effect on the membrane potential in single frog skeletal muscle fibers. Therefore, it is possible that binding of La 3ϩ and Cd 2ϩ or nifedipine with the DHPR induces the preactivated state of DHPR. It follows that this conformational transition could influence a long-range allosteric interaction between the DHPR and RyR1 that enhances the sensitivity of wtRyR1 to caffeine. Unlike wtRyR1, wtRyR2 failed to alter its responses to any of the applied caffeine doses in the presence of La 3ϩ and Cd 2ϩ or nifedipine. The most likely explanation for the lack of influence of a DHPR block on RyR2 function is that these channels do not physically couple with the DHPR, as demonstrated by the fact that RyR2 does not support bidirectional signaling. Rather, RyR2 is activated by Ca 2ϩ -induced Ca 2ϩ release that is initiated by Ca 2ϩ entry through DHPR (3, 42) .
The effects of La 3ϩ and Cd 2ϩ or nifedipine via the DHPR on caffeine sensitivity could also reflect the influence of several other factors, including a change in L-type Ca 2ϩ current magnitude, [Ca 2ϩ ] i , or membrane potential. Our hypothesis that the change is due to induction of a preactivated DHPR state by La 3ϩ and Cd 2ϩ or nifedipine would suggest a nonconducting conformational change of the DHPR, rather than an alteration of the actively open DHPR. However, without measuring DHPR current, we cannot definitively rule out a reduction in retrograde signaling, which would be revealed as a difference in Ca 2ϩ current as the mechanism for this change in caffeine sensitivity. However, the changes in caffeine sensitivity of either wtRyR1 or the two chimeras induced by DHPR blockade cannot be explained by a simple difference in resting free Ca 2ϩ or membrane potential among the constructs because there is no difference. Also, it is unlikely that the decreased caffeine sensitivities in the presence of La 3ϩ and Cd 2ϩ or nifedipine seen in cells expressing R4 and R9 can be explained simply on the basis of their observed decreased SR Ca 2ϩ contents (Figs. 3, 4, and 6 ). It has been reported in rabbit and frog skeletal SR that the rate constant of Ca 2ϩ release parallels the luminal Ca 2ϩ concentration (5, 12, 14) . At the singlechannel level, increasing luminal Ca 2ϩ favored channel activation by increasing the duration of open events of both cardiac and skeletal RyRs (12, (43) (44) (45) 48) . Therefore, even though it is possible that one of regulatory factors of the long-range allosteric interaction between the DHPR and RyR1 that could affect the sensitivity of wtRyR1 to caffeine could be luminal Ca 2ϩ , it is unlikely that the decreased caffeine sensitivities of R4 and R9 after DHPR blockade are secondary to their decreased SR Ca 2ϩ contents, because caffeine sensitivities of R4 and R9 were different from that of wtRyR1 under control condition ( Fig. 2B and Table 1 ). Therefore, RyR1 appears to act as a complex integrator of multiple regulatory stimuli including changes in the DHPR and endogenous effectors such as cytoplasmic and luminal Ca 2ϩ . Taking all the results together, the negative allosteric interaction seen after treatment with the two DHPR blockers with the two RyR1-RyR2 chimeras R4 and R9 compared with the positive allosteric interaction seen with wtRyR1 demonstrates that, like the molecular interactions responsible for EC cou- (10, 38) , DHPRs form tetrad structures appearing to be connected with alternate feet in 1B5 myotubes expressing RyR1, suggesting a functional link between RyR1 and the DHPR. On the other hand, R10 and R16 form incomplete tetrads of DHPRs that exhibit an irregularly spaced pattern. However, R4 and R9 show the same tendency for tetrad formation as RyR1, suggesting that the R9 region has this important functional link with the DHPR and that this link could be one of the regulatory factors for a functional module in the R9 region of RyR1 (R9 RyR1 ).
It has been reported that calmodulin (CaM) inhibits Ca 2ϩ -, caffeine-, and AMP-induced Ca 2ϩ release from cardiac and skeletal muscle SR (11, 21, 22, 35) . Plank et al. (35) found that the caffeine-induced Ca 2ϩ release from actively loaded SR vesicles is reduced to 51% of the respective control value by 1 M exogenous CaM. Furthermore, it was reported that a synthetic peptide containing residues 3,614 to 3,643 of the RyR1 was found to be capable of binding with high affinity either apo-CaM or Ca 2ϩ /CaM (23, 40) , suggesting that CaM could participate as a negative module in R9 RyR1 .
In addition to orthograde regulation of RyR1, further work aimed at understanding the structural determinants within R9 RyR1 that contribute to negative modulation should clarify whether initial activation and inactivation mechanisms of RyR1 and RyR2 during EC coupling differ. However, on the basis of present results with R4 and R9, the chimeric approach may not be a viable strategy given the confounding influence of long-range allosterism. A more direct approach using sitedirected mutations or scrambling short sequences within R9 RyR1 is likely to be more informative. malignant hyperthermia-susceptible swine skeletal muscle to caffeine is mediated by high resting myoplasmic [Ca 2ϩ ]. 
